Donald P. Tashkin, MD
University of California, Los Angeles
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Robert M. Elashoff, PhD
UCLA School of Public Health
Shared therapeutic areas:
Worked with same sponsors:
Michael D. Roth, MD
University of California, Los Angeles
Shared therapeutic areas:
Worked with same sponsors:
Konrad E Bloch, MD
University Hospital, Zürich
Shared therapeutic areas:
Steven E. Linberg, PhD
Chiesi Farmaceutici S.p.A.
Shared therapeutic areas:
Worked with same sponsors:
Nikolaos Harokopos, MD
General hospital of Pyrgos, Peloponnese, Greece
Shared therapeutic areas:
Anastasios Palamidas, MD
Sotiria Pulmonary Hospital of Athens
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Anna Gavriilidou, MD
Papageorgiou hospital of Thessaloniki, Greece
Shared therapeutic areas:
Talant M Sooronbaev, MD
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Shared therapeutic areas:
Mitesh Patel, MD, MBA, MS
University of Pennsylvania
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
All 2 trials loaded